[go: up one dir, main page]

TR201721065A2 - Lyophilized pharmaceutical formulations comprising dexmedetomidine - Google Patents

Lyophilized pharmaceutical formulations comprising dexmedetomidine Download PDF

Info

Publication number
TR201721065A2
TR201721065A2 TR2017/21065A TR201721065A TR201721065A2 TR 201721065 A2 TR201721065 A2 TR 201721065A2 TR 2017/21065 A TR2017/21065 A TR 2017/21065A TR 201721065 A TR201721065 A TR 201721065A TR 201721065 A2 TR201721065 A2 TR 201721065A2
Authority
TR
Turkey
Prior art keywords
dexmedetomidine
pharmaceutical formulations
lyophilized pharmaceutical
lyophilized
pharmaceutically acceptable
Prior art date
Application number
TR2017/21065A
Other languages
Turkish (tr)
Inventor
Türkyilmaz Ali̇
Yelken Gülay
Saray Duygu
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/21065A priority Critical patent/TR201721065A2/en
Publication of TR201721065A2 publication Critical patent/TR201721065A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to stable lyophilized pharmaceutical formulations comprising dexmedetomidine or a pharmaceutically acceptable salt thereof.
TR2017/21065A 2017-12-21 2017-12-21 Lyophilized pharmaceutical formulations comprising dexmedetomidine TR201721065A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/21065A TR201721065A2 (en) 2017-12-21 2017-12-21 Lyophilized pharmaceutical formulations comprising dexmedetomidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/21065A TR201721065A2 (en) 2017-12-21 2017-12-21 Lyophilized pharmaceutical formulations comprising dexmedetomidine

Publications (1)

Publication Number Publication Date
TR201721065A2 true TR201721065A2 (en) 2019-07-22

Family

ID=67900863

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/21065A TR201721065A2 (en) 2017-12-21 2017-12-21 Lyophilized pharmaceutical formulations comprising dexmedetomidine

Country Status (1)

Country Link
TR (1) TR201721065A2 (en)

Similar Documents

Publication Publication Date Title
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2020009857A (en) Il-2 conjugates.
MX2017016802A (en) Pharmaceutical formulations.
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
SG10201902203VA (en) Eutectic formulations of cyclobenzaprine hydrochloride
SG11202109102PA (en) Pharmaceutical formulations
MX2020012989A (en) Therapeutic agent for fibrosis.
WO2020123753A3 (en) Anellosomes for delivering intracellular therapeutic modalities
EP4331622A3 (en) Integrin binding peptides and uses thereof
ZA202006570B (en) Pharmaceutical formulations
MX2018005358A (en) Optimised high-dose mesalazine-containing tablet.
EA033314B1 (en) ANTIBACTERIALS COMPRISING PYRAZINO[2,3-b][1,4]OXAZIN-3-ONE OR A RELATED RING SYSTEM
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
PH12018501758A1 (en) Oritavancin formulations
PH12017501955A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease
IL271908A (en) Hypercompressed pharmaceutical formulations
WO2016020408A3 (en) Compounds for preventing ototoxicity
SG11202010792TA (en) Improved pharmaceutical formulations
IN2014MU00859A (en)
TR201721065A2 (en) Lyophilized pharmaceutical formulations comprising dexmedetomidine
EA201691422A1 (en) ORIGINALLY FALLING TABLETED MEMANTINE COMPOSITIONS